Arsenal Medical Launches EMBO-02 Study for NeoCast™ to Assess Treatment of Chronic Subdural Hematoma
First Patient Enrolled in Trial to Evaluate Safety and Feasibility of Innovative Embolic Agent in Expanded Patient Population Utilizing Middle Meningeal Artery Embolization (MMAe) Arsenal Medical, a ...
Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback